Representative Tom Price of Georgia, Mr. Trump’s nominee to be secretary of health and human services, purchased shares of Innate four times in 2015 and 2016, according to congressional financial disclosures, totaling between $60, 000 and $110, 000. Other Washington power players with investments in the company include Michael Hook, Mr. Collins’s chief of staff, who is a top shareholder, and Bill Paxon, a Washington lobbyist and former congressman, according to company filings and congressional financial disclosures. Last summer, Mr. Price, Mr. Hook and Mr. Paxon bought the stock at a discount as part of a private offering organized by Innate aimed at "sophisticated U. S. investors. " 